OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
Priyamadhaba Behera, Arvind Kumar Singh, Sonu Hangma Subba, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 43
Priyamadhaba Behera, Arvind Kumar Singh, Sonu Hangma Subba, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India
Upinder Kaur, Zeba Fatima, Kalika Maheshwari, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 553-563
Open Access | Times Cited: 15
Upinder Kaur, Zeba Fatima, Kalika Maheshwari, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 553-563
Open Access | Times Cited: 15
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters
Jyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Jyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Multi-strain COVID-19 dynamics with vaccination strategies: Mathematical modeling and case study
Venkatesh Ambalarajan, Ankamma Rao Mallela, Prasantha Bharathi Dhandapani, et al.
Alexandria Engineering Journal (2025) Vol. 119, pp. 665-684
Closed Access
Venkatesh Ambalarajan, Ankamma Rao Mallela, Prasantha Bharathi Dhandapani, et al.
Alexandria Engineering Journal (2025) Vol. 119, pp. 665-684
Closed Access
Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 Mpro, Revealing Its Biophysical Impact on Structural Stability
Sarika Bano, Jyotishna Singh, Zainy Zehra, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
Sarika Bano, Jyotishna Singh, Zainy Zehra, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
COVID-19 Vaccines, Effectiveness, and Immune Responses
Haneen I. Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15415-15415
Open Access | Times Cited: 26
Haneen I. Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15415-15415
Open Access | Times Cited: 26
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 826-826
Open Access | Times Cited: 13
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 826-826
Open Access | Times Cited: 13
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
Martin Law, Sam S.H. Ho, Gigi Kwan Chi Tsang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 37, pp. 100788-100788
Open Access | Times Cited: 12
Martin Law, Sam S.H. Ho, Gigi Kwan Chi Tsang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 37, pp. 100788-100788
Open Access | Times Cited: 12
Antiphospholipid syndrome in the era of COVID-19 – Two sides of a coin
Naim Mahroum, Mona Habra, Mohamad Aosama Alrifaai, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103543-103543
Closed Access | Times Cited: 4
Naim Mahroum, Mona Habra, Mohamad Aosama Alrifaai, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103543-103543
Closed Access | Times Cited: 4
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1363-1376
Open Access | Times Cited: 15
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1363-1376
Open Access | Times Cited: 15
Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs
Ranjeet Maurya, Uzma Shamim, Pallavi Mishra, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 8
Ranjeet Maurya, Uzma Shamim, Pallavi Mishra, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 8
Myocarditis: causes, mechanisms, and evolving therapies
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 7
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 7
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis
Aashish Contractor, Shashikala Shivaprakash, Anjali Tiwari, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0276759-e0276759
Open Access | Times Cited: 10
Aashish Contractor, Shashikala Shivaprakash, Anjali Tiwari, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0276759-e0276759
Open Access | Times Cited: 10
Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2064-2077
Open Access | Times Cited: 5
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2064-2077
Open Access | Times Cited: 5
Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis
Xiuhong Yang, Hua Zhang, Wenjing Bao, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2070-2070
Open Access | Times Cited: 9
Xiuhong Yang, Hua Zhang, Wenjing Bao, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2070-2070
Open Access | Times Cited: 9
COVID-19 Vaccine Hesitancy Among Healthcare Workers: A Phenomenological Study of Skepticism
Parvathy Thampy, Shweta Sharma, Pragya Joshi, et al.
Cureus (2024)
Open Access | Times Cited: 1
Parvathy Thampy, Shweta Sharma, Pragya Joshi, et al.
Cureus (2024)
Open Access | Times Cited: 1
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review
Oliver Galgut, Fiona Ashford, Alexandra Deeks, et al.
Vaccine X (2024) Vol. 20, pp. 100546-100546
Open Access | Times Cited: 1
Oliver Galgut, Fiona Ashford, Alexandra Deeks, et al.
Vaccine X (2024) Vol. 20, pp. 100546-100546
Open Access | Times Cited: 1
Efficacy and prognostic factors of COVID ‐19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study
He Zhao, Ying Li, Pengfei Tian, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
He Zhao, Ying Li, Pengfei Tian, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Serological Evaluation of Antibody Titers After Vaccination Against COVID-19 in 18-44-Year-Old Individuals at a Tertiary Care Center
Rachita Nanda, Prishni Gupta, A. Giri, et al.
Cureus (2023)
Open Access | Times Cited: 4
Rachita Nanda, Prishni Gupta, A. Giri, et al.
Cureus (2023)
Open Access | Times Cited: 4
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults
Prasad S. Kulkarni, Bhagwat Gunale, Sunil Kohli, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Prasad S. Kulkarni, Bhagwat Gunale, Sunil Kohli, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China
Wei Qin, Xiaqing Zhang, Xiaojing Yao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7
Wei Qin, Xiaqing Zhang, Xiaojing Yao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7
Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
Pragya D. Yadav, Sreelekshmy Mohandas, Anita M. Shete, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105178-105178
Open Access | Times Cited: 7
Pragya D. Yadav, Sreelekshmy Mohandas, Anita M. Shete, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105178-105178
Open Access | Times Cited: 7
Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductiveage Women: A Multi-centric Observational Study
Naina Kumar, Neha Gangane, Ipsita Mohapatra, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 2, pp. 237-248
Closed Access | Times Cited: 3
Naina Kumar, Neha Gangane, Ipsita Mohapatra, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 2, pp. 237-248
Closed Access | Times Cited: 3
